Subscribe to:
AIDSmeds & POZ newsletters
POZ magazine
Personals Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Hormonally Challenged
Montaner: Treat HIV to Help Curb Infection Spread
Ready to Quit? The Risks and Rewards of a Potent Smoking-Cessation Drug
Zinc Fingers to the Fore
Deep Vein Clotting Risk Higher in HIV
Experimental HIV Drug Hits Snag
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from CancerWEB's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Herpes Simplex Virus
Syphilis & Neurosyphilis
Shingles
The HIV Life Cycle
Human Papilloma Virus (HPV)
Treatments for Opportunistic Infections (OIs)
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

March 15, 2007

Early HCV Response Predicts Outcome
(Reuters Health)

Early virologic response to an interferon-based regimen plus ribavirin for hepatitis C virus (HCV) infection predicts sustained virologic response in patients who are also infected with HIV.

Several studies have already shown that early virologic response predicts sustained virologic response in patients infected with only HCV, Dr. Montserrat Laguno from Hospital Clinic Universitari de Barcelona, and associates explain. But it is unclear whether this holds true in patients co-infected with HIV and HCV.

Dr. Laguno's group investigated the utility of an early virologic response to predict a sustained virologic response to HCV therapy in 95 co-infected patients.

Early virologic response was associated with a sustained virologic response, with a positive predictive value of 64%, the authors report in the February 1st issue of the Journal of Acquired Immune Deficiency Syndromes. In contrast, none of the patients without an early virologic response had a sustained virologic response, the report indicates.

Achieving undetectable HCV RNA at week 4 (a very early virologic response) predicted sustained virologic response with a positive predictive value of 89% and a negative predictive value of 70%, the researchers note.

A very early virologic response had higher positive predictive value for sustained virologic response when patients received pegylated interferon as opposed to interferon, the results indicate.

"The results of our study suggest that the rules of reduction of 2 log of the viral load at week 12 of HCV therapy in co-infected patients have the same value as those in mono-infected patients," the investigators conclude.

J Acquir Immune Defic Syndr 2007;44:174-178.



Copyright © 2007 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

emailrssprint


[Go to top]

Get Started
Get Answers
I'm HIV positive. What's next?
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS

Conference Coverage

XVII International AIDS Conference
Mexico City, Mexico
August 3-8, 2008
COMING SOON

CROI 2008
Boston, MA
February 3-8, 2008


2007 National Prevention Conference
Atlanta
December 2-7, 2007


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertise/contact us]

© 2008 Smart + Strong. All Rights Reserved. Terms of use and Your privacy